Buck Trust to Finance Aging Center

SAN FRANCISCO—A California court has awarded a $65 million en- dowment from the Buck Trust to begin a multidisciplinary research institute on aging. The Buck Center on Aging, to be built in Main County, will be affiliated with the Berkeley, San Francisco and Davis campuses of the University of California system. The center expects to open in 1992 with a research staff of 60, including 15 senior researchers, and an annual operating budget of $4.5 million. The staff is expected to grow to

Written byRobert Brylawski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SAN FRANCISCO—A California court has awarded a $65 million en- dowment from the Buck Trust to begin a multidisciplinary research institute on aging.

The Buck Center on Aging, to be built in Main County, will be affiliated with the Berkeley, San Francisco and Davis campuses of the University of California system. The center expects to open in 1992 with a research staff of 60, including 15 senior researchers, and an annual operating budget of $4.5 million. The staff is expected to grow to around 30 senior researchers and 180 scientists.

Researchers in aging are enthusiastic about the new center. “A privately endowed research center on such a grand scale in a beautiful place, affiliated with a great university, is unprecedented,” said Harvard University gerontologist John Rowe. Several aspects of the center are particularly exciting, he added, including its interdisciplinary approach, the prospect of training many young research scientists and its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies